Global Blood Therapeutics - 4 Year Stock Price History | GBT

Historical daily share price chart and data for Global Blood Therapeutics since 2015 adjusted for splits. The latest closing stock price for Global Blood Therapeutics as of July 16, 2019 is 55.66.
  • The all-time high Global Blood Therapeutics stock price is 65.90, which is 18.4% above the current share price.
  • The Global Blood Therapeutics 52-week high stock price is 63.29, which is 13.7% above the current share price.
  • The Global Blood Therapeutics 52-week low stock price is 31.54, which is 43.3% below the current share price.
  • The average Global Blood Therapeutics stock price for the last 52 weeks is 47.70.
Global Blood Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 53.5612 41.1300 63.2900 39.9900 55.6600 35.59%
2018 45.6882 41.6000 65.9000 31.5400 41.0500 4.32%
2017 30.1224 14.3000 45.7000 14.3000 39.3500 172.32%
2016 18.6577 29.2100 29.2100 12.9500 14.4500 -55.30%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.140B $0.000B
Global Blood Therapeutics, Inc. is a biopharmaceutical company which is engaged in discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. Its product candidate consists of GBT440 is an oral, once-daily prophylactic therapy for sickle cell disease which is in clinical trial. The company in addition to GBT is involved in research and development activities targeted hypoxemic pulmonary disorders, including idiopathic pulmonary fibrosis and hereditary angioedema. Global Blood Therapeutics, Inc. is based in South San Francisco, California.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $108.245B 12.24
Gilead Sciences (GILD) United States $85.342B 10.36
Celgene (CELG) United States $64.552B 10.94
Vertex Pharmaceuticals (VRTX) United States $45.118B 54.54
Biogen (BIIB) United States $44.896B 8.52
Illumina (ILMN) United States $44.438B 51.50
CSL (CSLLY) Australia $35.409B 0.00
Regeneron Pharmaceuticals (REGN) United States $32.605B 15.32
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $27.541B 15.59
Incyte (INCY) United States $17.129B 69.46
Exact Sciences (EXAS) United States $14.845B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.750B 0.00
SINO PHARMACEUT (SBMFF) China $14.154B 0.00
Sarepta Therapeutics (SRPT) United States $11.364B 0.00
Genmab (GNMSF) Denmark $11.067B 56.26
Array BioPharma (ARRY) United States $10.346B 0.00
Seattle Genetics (SGEN) United States $10.192B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.283B 49.21
QIAGEN (QGEN) Netherlands $8.908B 29.26
Galapagos (GLPG) Belgium $8.802B 0.00
Bio-Techne Corp (TECH) United States $7.964B 54.34
Alnylam Pharmaceuticals (ALNY) United States $7.909B 0.00
Guardant Health (GH) United States $7.720B 0.00
Bluebird Bio (BLUE) United States $7.368B 0.00
Amarin (AMRN) Ireland $7.189B 0.00
Exelixis (EXEL) United States $6.482B 16.52
BeiGene (BGNE) Cayman Islands $5.652B 0.00
Ascendis Pharma (ASND) Denmark $4.867B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.719B 0.00
Moderna (MRNA) United States $4.652B 0.00
Blueprint Medicines (BPMC) United States $4.628B 0.00
Horizon Pharma Public (HZNP) Ireland $4.408B 11.35
Repligen (RGEN) United States $4.177B 104.05
ACADIA Pharmaceuticals (ACAD) United States $3.787B 0.00
Spark Therapeutics (ONCE) United States $3.752B 0.00
Mirati Therapeutics (MRTX) United States $3.729B 0.00
China Biologic Products (CBPO) China $3.682B 23.39
Alkermes (ALKS) Ireland $3.668B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.401B 0.00
MorphoSys AG (MOR) Germany $3.316B 0.00
Arena Pharmaceuticals (ARNA) United States $3.062B 6.22
Amicus Therapeutics (FOLD) United States $2.899B 0.00
Immunomedics (IMMU) United States $2.772B 0.00
Medicines (MDCO) United States $2.740B 0.00
UniQure (QURE) Netherlands $2.631B 0.00
Reata Pharmaceuticals (RETA) United States $2.613B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.566B 0.00
Halozyme Therapeutics (HALO) United States $2.468B 0.00
MyoKardia (MYOK) United States $2.308B 0.00
Ligand Pharmaceuticals (LGND) United States $2.299B 19.04
Nabriva Therapeutics AG (NBRV) Ireland $2.251B 0.00
Emergent Biosolutions (EBS) United States $2.231B 19.38
NeoGenomics (NEO) United States $2.216B 145.06
Acceleron Pharma (XLRN) United States $2.160B 0.00
Zai Lab (ZLAB) China $2.106B 0.00
Genomic Health (GHDX) United States $2.078B 44.13
Akcea Therapeutics (AKCA) United States $2.072B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.046B 0.00
Denali Therapeutics (DNLI) United States $1.911B 0.00
Myriad Genetics (MYGN) United States $1.907B 18.97
REGENXBIO (RGNX) United States $1.720B 0.00
Insmed (INSM) United States $1.690B 0.00
Cambrex (CBM) United States $1.501B 18.98
Fate Therapeutics (FATE) United States $1.464B 0.00
AnaptysBio (ANAB) United States $1.431B 0.00
RA PHARMCTL INC (RARX) United States $1.421B 0.00
Innoviva (INVA) United States $1.405B 3.89
Sangamo Therapeutics (SGMO) United States $1.349B 0.00
Athenex (ATNX) United States $1.329B 0.00
Alector (ALEC) United States $1.311B 0.00
Coherus BioSciences (CHRS) United States $1.284B 0.00
Editas Medicine (EDIT) United States $1.198B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.185B 0.00
Epizyme (EPZM) United States $1.174B 0.00
Cara Therapeutics (CARA) United States $1.036B 0.00
Codexis (CDXS) United States $1.031B 0.00
Adverum Biotechnologies (ADVM) United States $1.013B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.013B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.979B 0.00
ANI Pharmaceuticals (ANIP) United States $0.976B 17.31
Twist Bioscience (TWST) United States $0.963B 0.00
Principia Biopharma (PRNB) United States $0.955B 0.00
Zymeworks (ZYME) Canada $0.940B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.928B 0.00
WAVE Life Sciences (WVE) Singapore $0.924B 0.00
Retrophin (RTRX) United States $0.873B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.873B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.856B 0.00
Vericel (VCEL) United States $0.854B 0.00
Arvinas (ARVN) United States $0.811B 0.00
Intellia Therapeutics (NTLA) United States $0.755B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.712B 33.60
Precision BioSciences (DTIL) United States $0.699B 0.00
Zealand Pharma (ZEAL) Denmark $0.683B 7.99
Zealand Pharma (ZLDPF) Denmark $0.683B 0.00
Clovis Oncology (CLVS) United States $0.678B 0.00
Cytokineticsorporated (CYTK) United States $0.668B 0.00
Cellectis S.A (CLLS) France $0.647B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.640B 0.00
Intra-Cellular Therapies (ITCI) United States $0.640B 0.00
Heska (HSKA) United States $0.617B 63.16
DBV Technologies S.A (DBVT) France $0.604B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.589B 0.00
Anika Therapeutics (ANIK) United States $0.579B 19.79
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.575B 0.00
Stemline Therapeutics (STML) United States $0.568B 0.00
MiMedx (MDXG) United States $0.546B 0.00
Revance Therapeutics (RVNC) United States $0.542B 0.00
CytomX Therapeutics (CTMX) United States $0.537B 0.00
Pharming Group (PHGUF) Netherlands $0.521B 0.00
Mesoblast (MESO) Australia $0.504B 0.00
PHARMA MAR SA (PHMMF) Spain $0.454B 0.00
UROGEN PHARMA (URGN) United States $0.447B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.442B 0.00
Puma Biotechnology (PBYI) United States $0.417B 0.00
Prothena (PRTA) Ireland $0.386B 0.00
Biofrontera AG (BFRA) Germany $0.385B 0.00
PDL BioPharma (PDLI) United States $0.379B 9.06
AC Immune SA (ACIU) Switzerland $0.377B 24.26
Arcus Biosciences (RCUS) United States $0.376B 0.00
Gritstone Oncology (GRTS) United States $0.373B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Bellus Health (BLUSF) Canada $0.366B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.365B 0.00
Scholar Rock Holding (SRRK) United States $0.359B 0.00
Avid Bioservices (CDMO) United States $0.359B 0.00
Merus (MRUS) Netherlands $0.359B 0.00
Starpharma Holdings (SPHRY) Australia $0.356B 0.00
Prometic Life Sciences (PFSCD) Canada $0.348B 0.00
Albireo Pharma (ALBO) United States $0.346B 0.00
Agenus (AGEN) United States $0.344B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.343B 0.00
BioDelivery Sciences (BDSI) United States $0.340B 0.00
Senesco Technologies (ELOX) United States $0.337B 0.00
Acorda Therapeutics (ACOR) United States $0.331B 5.83
Kadmon Holdings (KDMN) United States $0.329B 0.00
Theratechnologies (THERF) Canada $0.328B 0.00
Syros Pharmaceuticals (SYRS) United States $0.324B 0.00
Protagonist Therapeutics (PTGX) United States $0.309B 0.00
Sorrento Therapeutics (SRNE) United States $0.308B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.304B 0.00
Inovio Pharmaceuticals (INO) United States $0.294B 0.00
Cellular Biomedicine (CBMG) United States $0.270B 0.00
Kindred Biosciences (KIN) United States $0.269B 0.00
PHASEBIO PHARMA (PHAS) United States $0.263B 0.00
ChromaDex (CDXC) United States $0.262B 0.00
Sutro Biopharma (STRO) United States $0.261B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.260B 0.00
Dynavax Technologies (DVAX) United States $0.252B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.247B 0.00
Kamada (KMDA) Israel $0.238B 9.22
ADMA Biologics Inc (ADMA) United States $0.233B 0.00
Athersys (ATHX) United States $0.232B 0.00
Geron (GERN) United States $0.226B 0.00
Palatin Technologies (PTN) United States $0.222B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.221B 0.00
Cel-Sci (CVM) United States $0.220B 0.00
Cerecor (CERC) United States $0.210B 0.00
MannKind (MNKD) United States $0.205B 0.00
Five Prime Therapeutics (FPRX) United States $0.204B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.198B 0.00
CorMedix Inc (CRMD) United States $0.198B 0.00
Abeona Therapeutics (ABEO) United States $0.196B 0.00
Synlogic (SYBX) United States $0.195B 0.00
Mersana Therapeutics (MRSN) United States $0.191B 0.00
Affimed (AFMD) Germany $0.191B 0.00
OSMOTICA PHARM (OSMT) United States $0.186B 0.00
Pfenex (PFNX) United States $0.186B 0.00
Spero Therapeutics (SPRO) United States $0.185B 0.00
POXEL SA FRANCE (PXXLF) $0.184B 0.00
Arsanis (XFOR) United States $0.183B 0.00
Compugen (CGEN) Israel $0.182B 0.00
Enzo Biochem (ENZ) United States $0.178B 0.00
BioTime (BTX) United States $0.177B 11.80
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Nicox SA (NICXF) France $0.163B 0.00
XOMA (XOMA) United States $0.158B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.157B 0.00
Strongbridge Biopharma (SBBP) United States $0.150B 8.63
OvaScience (MLND) United States $0.148B 0.00
Cue Biopharma (CUE) United States $0.148B 0.00
TOCAGEN INC (TOCA) United States $0.142B 0.00
Liquidia Technologies (LQDA) United States $0.140B 0.00
Adocia (ADOCY) France $0.140B 0.00
Celyad SA (CYAD) Belgium $0.140B 0.00
Northwest Biotherapeutics (NWBO) United States $0.135B 0.00
Dyadic (DYAI) United States $0.134B 0.00
NantKwest (NK) United States $0.127B 0.00
Seres Therapeutics (MCRB) United States $0.125B 0.00
Aptinyx (APTX) United States $0.123B 0.00
Alcobra (ARCT) United States $0.120B 0.00
Arbutus Biopharma (ABUS) Canada $0.119B 0.00
Aduro Biotech (ADRO) United States $0.119B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.119B 0.00
Menlo Therapeutics (MNLO) United States $0.118B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.117B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.116B 0.00
Verastem (VSTM) United States $0.114B 0.00
Novavax (NVAX) United States $0.109B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.103B 0.00
Catalyst Biosciences (CBIO) United States $0.103B 0.00
Checkpoint Therapeutics (CKPT) United States $0.103B 0.00
SESEN BIO, INC (SESN) United States $0.100B 0.00
Trevena (TRVN) United States $0.097B 0.00
Curis (CRIS) United States $0.094B 0.00
Fortress Biotech (FBIO) United States $0.093B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.085B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.084B 0.00
Pluristem Therapeutics (PSTI) Israel $0.084B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.083B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.083B 0.00
VBI Vaccines (VBIV) United States $0.082B 0.00
AquaBounty Technologies (AQB) United States $0.081B 0.00
Unum Therapeutics (UMRX) United States $0.079B 0.00
VTv Therapeutics (VTVT) United States $0.078B 0.00
Selecta Biosciences (SELB) United States $0.075B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.073B 0.00
Idera Pharmaceuticals (IDRA) United States $0.073B 0.00
Signal Genetics (MGEN) United States $0.072B 0.00
Orgenesis (ORGS) United States $0.072B 0.00
Applied Genetic Technologies (AGTC) United States $0.069B 37.90
Organovo Holdings (ONVO) United States $0.067B 0.00
ARAVIVE, INC (ARAV) United States $0.063B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.062B 0.00
Alimera Sciences (ALIM) United States $0.062B 0.00
Protalix BioTherapeutics (PLX) Israel $0.060B 0.00
Antibe Therapeutics (ATBPF) Canada $0.060B 0.00
Prima BioMed (IMMP) Australia $0.059B 0.00
Invo BioScience (IVOB) United States $0.057B 0.00
NewLink Genetics (NLNK) United States $0.054B 0.00
Oncobiologics (OTLK) United States $0.053B 0.00
Ophthotech (ISEE) United States $0.051B 0.00
Proteostasis Therapeutics (PTI) United States $0.050B 0.00